We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
-5.87%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.11B
AUM Growth
-$636M
(-17%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-11.42%
Top 10 Holdings %
Top 10 Hldgs %
18.55%
Holding
435
New
67
Increased
62
Reduced
121
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$28.9M |
| 2 |
CVS Health
CVS
|
+$27.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$25M |
| 4 |
UnitedHealth
UNH
|
+$20.4M |
| 5 |
Salesforce
CRM
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$43.8M |
| 2 |
iShares MSCI Japan ETF
EWJ
|
+$42.6M |
| 3 |
Coca-Cola
KO
|
+$40M |
| 4 |
Illumina
ILMN
|
+$31.6M |
| 5 |
Hain Celestial
HAIN
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.74% |
| 2 | Technology | 17.53% |
| 3 | Consumer Discretionary | 16.73% |
| 4 | Industrials | 11.77% |
| 5 | Energy | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Integer Holdings
ITGR
$4.29B
| $6.47M | 0.21% |
+125,863
| New | +$6.29M |
|
|
BCR
127
DELISTED
CR Bard Inc.
BCR
| $6.44M | 0.21% |
34,570
+11,400
| +49% | +$2.16M |
|
128
Red Robin
RRGB
$137M
| $6.4M | 0.21% |
84,452
+15,072
| +22% | +$1.27M |
|
129
EXL Service
EXLS
$5.5B
| $6.39M | 0.21% |
+864,635
| New | +$6.4M |
|
|
TTSH
130
DELISTED
Tile Shop Holdings
TTSH
| $6.35M | 0.2% |
530,232
-27,023
| -5% | -$358K |
|
131
Chegg
CHGG
$82.4M
| $6.33M | 0.2% |
878,010
-44,665
| -5% | -$354K |
|
|
SUM
132
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $6.32M | 0.2% |
+356,872
| New | +$8.22M |
|
133
Equifax
EFX
$19.6B
| $6.23M | 0.2% |
64,150
+7,950
| +14% | +$790K |
|
134
Paylocity
PCTY
$7.81B
| $6.23M | 0.2% |
207,693
+943
| +0.5% | +$32.1K |
|
135
Monster Beverage
MNST
$87.4B
| $6.14M | 0.2% |
+544,980
| New | +$6.39M |
|
136
Under Armour
UAA
$2.13B
| $6.05M | 0.19% |
125,080
-10,000
| -7% | -$475K |
|
|
CAVM
137
DELISTED
Cavium, Inc.
CAVM
| $6.04M | 0.19% |
98,335
+60,860
| +162% | +$4.06M |
|
|
IMS
138
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $6.03M | 0.19% |
+207,255
| New | +$6.36M |
|
|
CBM
139
DELISTED
Cambrex Corporation
CBM
| $5.96M | 0.19% |
150,116
-29,659
| -16% | -$1.39M |
|
140
D.R. Horton
DHI
$39.2B
| $5.87M | 0.19% |
200,000
| – | – |
|
|
ASRT
141
DELISTED
Assertio
ASRT
| $5.84M | 0.19% |
5,165
-826
| -14% | -$1.41M |
|
|
CXO
142
DELISTED
CONCHO RESOURCES INC.
CXO
| $5.82M | 0.19% |
59,240
+18,700
| +46% | +$1.96M |
|
143
Children's Place
PLCE
$42.3M
| $5.67M | 0.18% |
98,250
-4,236
| -4% | -$255K |
|
144
Paycom
PAYC
$10.2B
| $5.67M | 0.18% |
157,752
-8,023
| -5% | -$291K |
|
|
XXIA
145
DELISTED
Ixia
XXIA
| $5.65M | 0.18% |
+390,155
| New | +$5.56M |
|
146
LyondellBasell Industries
LYB
$21.1B
| $5.65M | 0.18% |
67,750
| – | – |
|
147
Martin Marietta Materials
MLM
$36B
| $5.59M | 0.18% |
36,820
-1,300
| -3% | -$210K |
|
148
Boyd Gaming
BYD
$5.53B
| $5.5M | 0.18% |
+337,615
| New | +$5.59M |
|
|
XENT
149
DELISTED
Intersect ENT, Inc
XENT
| $5.39M | 0.17% |
230,412
+13,823
| +6% | +$381K |
|
150
H&R Block
HRB
$5.65B
| $5.39M | 0.17% |
+148,925
| New | +$5.04M |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q3 2015 Portfolio in Review
As of Q3 2015, Castleark Management held 435 positions worth $3.11B, down 17% from $3.74B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Castleark Management withdrew a net $355M in Q3 2015, closing 71 positions and reducing 121 holdings. Its most notable exit was Aptiv, an estimated $43.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in Bristol-Myers Squibb worth $23.3M.
- Castleark Management's largest Q3 2015 buy was Bristol-Myers Squibb: 393,310 shares worth $23.3M.
- Castleark Management added most to Ulta Beauty in Q3 2015, an estimated $28.9M increase.
- Castleark Management's biggest Q3 2015 reduction was iShares MSCI Japan ETF, cutting an estimated $42.6M.
- Castleark Management fully exited Aptiv in Q3 2015, selling an estimated $43.8M.
- Castleark Management's ten largest holdings make up 19% of its $3.11B portfolio in Q3 2015.
- Castleark Management opened 67 new positions and closed 71 in Q3 2015.
- Castleark Management's portfolio value fell 17% quarter-over-quarter to $3.11B.
Based on Castleark Management's 13F filing for Q3 2015, filed 17 Nov 2015.